Even if exhaustive genetic studies on a large cohort of patients have not yet been performed, according to these preliminary results (Table 1), HCN1 mutations seem to involve infantile, severe, and progressive epileptic encephalopathies, while HCN2 appear to affect patients with normal intellective level, without evidence for a progressive disease. This evidence concerns the gene HCN1 and Epileptic encephalopathy.